Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
House Health Committee backs bill to restrict retail sales of chemically altered hemp products to 21+ licensed outlets
Summary
The committee voted to give a favorable report to a bill sponsored by Rep. Witt that would limit sales of certain hemp-derived products to 21-and-older, ABC-licensed stores with a 5-milligram cap; sponsors said federal law and product innovation limit the ability to fully ban synthetic variants.
Representative Witt introduced a bill aimed at limiting the retail availability of chemically altered hemp products, including delta-8 and delta-10 formulations, and the House Health Committee moved the measure forward on a pair of favorable reports.
Witt told the committee that a recent press release from Herbal Oasis, the parent company of CBDMD Inc., announced expanded distribution into convenience stores, grocery outlets and on-premise accounts such as bars and restaurants across Alabama and the Florida Panhandle; Witt said the bill is intended to prevent such on-premise and general retail sales. "This is exactly what we discussed last week that we were trying to do was stop this product…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
